Yüklüyor......
Repurposing Approach Identifies Auranofin with Broad Spectrum Antifungal Activity That Targets Mia40-Erv1 Pathway
Current antifungal therapies have limited effectiveness in treating invasive fungal infections. Furthermore, the development of new antifungal is currently unable to keep pace with the urgent demand for safe and effective new drugs. Auranofin, an FDA-approved drug for the treatment of rheumatoid art...
Kaydedildi:
| Yayımlandı: | Front Cell Infect Microbiol |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5241286/ https://ncbi.nlm.nih.gov/pubmed/28149831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcimb.2017.00004 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|